Janux Therapeutics Inc.

JANX | NASDAQ

Price Alert Chart Builder DCF Calculator

$17.22

+$0.21 (+1.23%)

Sep 22, 2026, 1:32 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-113.63M	-68.99M	-58.29M	-63.06M	-32.67M	-6.78M
Depreciation & Amortization	2.03M	2.06M	1.96M	841K	113K	13K
Stock-Based Compensation	40.22M	33.02M	20.01M	17.2M	6.91M	72K
Other Working Capital	5.74M	-899K	-6.83M	4.57M	-2.13M	8.38M
Other Non-Cash Items	-17.57M	-10.59M	-7.69M	-2.18M	-169K	1.94M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	6.71M	685K	-6.55M	4.28M	8.84M	389K
Operating Cash Flow	-82.24M	-43.81M	-50.58M	-42.92M	-16.98M	-4.37M
Capital Expenditures	-1.04M	-359K	-1.85M	-6.45M	-1.48M	n/a
Cash Acquisitions	n/a	n/a	n/a	-64.71M	339.48M	n/a
Purchase of Investments	-705.22M	-470.58M	-317.34M	-294.39M	-473.63M	n/a
Sales Maturities Of Investments	405.28M	212.92M	278M	359.1M	134.15M	n/a
Other Investing Acitivies	n/a	n/a	n/a	64.71M	-339.48M	n/a
Investing Cash Flow	-300.98M	-258.02M	-41.19M	58.27M	-340.96M	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	2.5M
Common Stock Repurchased	-347K	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	14.97M	3.02M	n/a	1.81M	70K
Financial Cash Flow	4.95M	713.24M	59.55M	500K	386.52M	11.52M
Net Cash Flow	-378.27M	411.4M	-32.22M	15.84M	28.59M	7.16M
Free Cash Flow	-83.28M	-44.17M	-52.43M	-49.37M	-18.46M	-4.37M
Adj. Free Cash Flow	-123.5M	-77.19M	-72.43M	-66.57M	-25.37M	-4.44M
Maintenance CapEx	-1.04M	n/a	-1.85M	n/a	n/a	n/a
Growth CapEx	n/a	-359K	n/a	-6.45M	-1.48M	n/a
Owner Earnings	-83.28M	-43.81M	-52.43M	-42.92M	-16.98M	-4.37M